Hotline - TAVI - Part 2

Anchorperson: H. Möllmann

Spokesperson: C. Zukowski

Summary

This session presents cutting-edge research comparing self-expanding and balloon-expandable valves in urgent and emergent TAVI settings, with a focus on small aortic annuli. It includes data from the NAVULTRA and LANDMARK trials, featuring novel biomimetic balloon-expandable valves and early feasibility studies that shed light on valve performance and patient outcomes at one year.

Presentations available when logged in:

Self- vs. balloon-expandable valves in patients undergoing urgent or emergent TAVI
Intra-annular self-expanding or balloon-expandable TAVI in small annuli: from NAVULTRA registry
Outcomes of a novel biomimetic balloon-expandable valve in small aortic annuli
Comparable one-year outcomes of Myval vs. contemporary transcatheter heart valves in small aortic annulus: LANDMARK trial
Comparative one-year outcomes of three transcatheter valves in the LANDMARK trial
Novel balloon-expandable transcatheter heart valve for aortic stenosis: initals insights from the early feasability study

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Hotline - TAVI - Part 2

Log in or create account for free